Literature DB >> 3542009

Passive Heymann nephritis in pre- and post-natal rats.

J Challice, A Z Barabas, J Cornish, J W Bruce, R Lannigan.   

Abstract

Passive Heymann nephritis (PHN) was induced in pre- and post-natal rats by a single intra-peritoneal injection of 0.2 ml of a rabbit anti-rat kidney fraction 3 (rKF3) antibody. Immune complex formation occurred only in those glomeruli or parts of glomeruli which were open to the circulation. Double staining of kidney sections for the glomerular nephritogenic antigen and rabbit IgG, 2 days after the injection of the antibody showed an identical distribution of both components in the glomeruli. In rats killed more than 4 days after the injection of the anti-rKF3 antibody, the nephritogenic antigen could be demonstrated in the subcapsular glomeruli, in the absence of rabbit IgG; and the same applied when the kidneys had reached maturity. When the injected antibody was expected to be present in the circulation, no nephritogenic antigen was demonstrated in the glomeruli in the absence of the heterologous IgG. These observations indicate that the nephritogenic antigen appears in the glomerulus at the same time as the glomerular capillary loops open to the circulation. Unlike PHN in the adult rat, the immune complexes in the glomeruli of neonatal rats do not persist longer than 84 days.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542009      PMCID: PMC2013121     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  8 in total

1.  Nephrotoxic serum nephritis in newborn rats.

Authors:  D K HAMMER; J J VAZQUEZ; F J DIXON
Journal:  Lab Invest       Date:  1963-01       Impact factor: 5.662

2.  Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis.

Authors:  B J Van Damme; G J Fleuren; W W Bakker; R L Vernier; P J Hoedemaeker
Journal:  Lab Invest       Date:  1978-04       Impact factor: 5.662

3.  Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. I. The natural history: a histologic and immunohistologic study at the light microscopic and the ultrastructural level.

Authors:  K Feenstra; R van den Lee; H A Greben; A Arends; P J Hoedemaeker
Journal:  Lab Invest       Date:  1975-02       Impact factor: 5.662

4.  Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis.

Authors:  T S Edgington; R J Glassock; F J Dixon
Journal:  Science       Date:  1967-03-17       Impact factor: 47.728

5.  Evaluation of homologous and isologous passive Heymann nephritis: influence on endogenous antibody production.

Authors:  C K Abrass; J McVay; R J Glassock
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

6.  Lower levels of thyrotropin-releasing hormone-degrading activity in human cord and in maternal sera than in the serum of euthyroid, nonpregnant adults.

Authors:  J T Neary; C Nakamura; I J Davies; M Soodak; F Maloof
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

7.  Studies with monoclonal antibodies against brush border antigens in Heymann nephritis.

Authors:  A K Bhan; E E Schneeberger; L G Baird; A B Collins; K Kamata; D Bradford; M E Erikson; R T McCluskey
Journal:  Lab Invest       Date:  1985-10       Impact factor: 5.662

8.  Passive Heymann-like nephritis in the rabbit.

Authors:  A Z Barabas; J Cornish; R Lannigan
Journal:  Br J Exp Pathol       Date:  1985-06
  8 in total
  2 in total

1.  Production of heterologous IgG antibody against Heymann nephritis antigen by injections of immune complexes.

Authors:  Arpad Z Barabas; Chad D Cole; Maria Sensen; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2011-11-22       Impact factor: 1.925

Review 2.  Regaining tolerance to a self-antigen by the modified vaccination technique.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere; Donald Mackay Weir
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.